HER2-Negative Breast Carcinoma
26 clinical trials · Condition
◉ Watch HER2-Negative Breast Carcinoma
| Record | Firm | Date |
|---|---|---|
| SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells (NCT04150042) | General Oncology, Inc. | 2021-01-13 |
| Testing the Addition of an Anti-cancer Drug, Berzosertib, to the Usual Treatment (Radiation Therapy) for Chemotherapy-Resistant Triple-Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast Cancer (NCT04052555) | National Cancer Institute (NCI) | 2020-09-24 |
| Vaccine Therapy in Treating Patients With HER2-Negative Stage III-IV Breast Cancer (NCT02157051) | University of Washington | 2015-06-01 |
Track HER2-Negative Breast Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.